Profile
Michael Biega is currently VP-Investor Relations & Communications at Harrow, Inc. since 2025.
Formerly, Mr. Biega was Managing Director at Solebury Strategic Communications LLC and Senior Director-Investor Relations at Sensei Biotherapeutics, Inc.
Michael Biega active positions
| Companies | Position | Start |
|---|---|---|
| HARROW, INC. | Investor Relations Contact | 18/06/2025 |
Former positions of Michael Biega
| Companies | Position | End |
|---|---|---|
Solebury Strategic Communications LLC
Solebury Strategic Communications LLC Miscellaneous Commercial ServicesCommercial Services Provides investor relations and corporate communications services | Corporate Officer/Principal | - |
| FAETH THERAPEUTICS, INC. | Investor Relations Contact | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Harrow, Inc.
Harrow, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development, production, and sale of innovative medications | Health Technology |
Solebury Strategic Communications LLC
Solebury Strategic Communications LLC Miscellaneous Commercial ServicesCommercial Services Provides investor relations and corporate communications services | Commercial Services |
Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
- Stock Market
- Insiders
- Michael Biega
















